Search clinical trials for: LY3819469

Total 5 results

Eli Lilly and Company

Completed

A Study to Compare Two Formulations of LY3819469 in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of LY3819469 in Healthy Participants

Healthy

United States, Singapore
Eli Lilly and Company

Completed

A Study of LY3819469 in Participants With Impaired and Normal Renal Function

Healthy | Renal Insufficiency

United States
Eli Lilly and Company

Active, not recruiting

A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]

Lipoprotein Disorder

United States, Spain, China, Japan, Germany, Argentina, Romania, Netherlands, Mexico, Denmark
Eli Lilly and Company

Recruiting

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Elevated Lp(a) | Atherosclerotic Cardiovascular Disease (ASCVD)

Taiwan, United States, Spain, Argentina, China, Italy, Australia, France, Canada, Japan, Belgium, Denmark, Germany, Hungary, Israel, Austria, Korea, Republic of, Brazil, Mexico, Netherlands, Romania, United Kingdom, Greece, Czechia, India, Slovak... and more

3

Subscribe